Related Experiment Video
Updated: Jun 22, 2025

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics
Published on: June 23, 2022
Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in Microglia
Christine A Bowen1, Hai M Nguyen2, Young Lin1
1Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia, USA; Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
Abstract:
Microglia are resident immune cells of the brain and regulate its inflammatory state. In neurodegenerative diseases, microglia transition from a homeostatic state to a state referred to as disease-associated microglia (DAM). DAM express higher levels of proinflammatory signaling molecules, like STAT1 and TLR2, and show transitions in mitochondrial activity toward a more glycolytic response. Inhibition of Kv1.3 decreases the proinflammatory signature of DAM, though how Kv1.3 influences the response is unknown. Our goal was to identify the potential proteins interacting with Kv1.3 during transition to DAM. We utilized TurboID, a biotin ligase, fused to Kv1.3 to evaluate potential interacting proteins with Kv1.3 via mass spectrometry in BV-2 microglia following TLR4-mediated activation. Electrophysiology, Western blotting, and flow cytometry were used to evaluate Kv1.3 channel presence and TurboID biotinylation activity. We hypothesized that Kv1.3 contains domain-specific interactors that vary during a TLR4-induced inflammatory response, some of which are dependent on the PDZ-binding domain on the C terminus. We determined that the N terminus of Kv1.3 is responsible for trafficking Kv1.3 to the cell surface and mitochondria (e.g., NUDC, TIMM50). Whereas, the C terminus interacts with immune signaling proteins in a lipopolysaccharide-induced inflammatory response (e.g., STAT1, TLR2, and C3). There are 70 proteins that rely on the C-terminal PDZ-binding domain to interact with Kv1.3 (e.g., ND3, Snx3, and Sun1). Furthermore, we used Kv1.3 blockade to verify functional coupling between Kv1.3 and interferon-mediated STAT1 activation. Overall, we highlight that the Kv1.3 potassium channel functions beyond conducting the outward flux of potassium ions in an inflammatory context and that Kv1.3 modulates the activity of key immune signaling proteins, such as STAT1 and C3.
Insights
Kv1.3 channel interacts with immune proteins like STAT1 and C3 in brain immune cells during inflammation. This reveals Kv1.3
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are brain immune cells regulating inflammation.
- Disease-associated microglia (DAM) show increased pro-inflammatory markers and altered metabolism.
- Kv1.3 channel inhibition reduces DAM pro-inflammatory signature, but its interaction mechanisms are unclear.
Purpose of the Study:
- To identify proteins interacting with Kv1.3 during the transition to DAM.
- To investigate the role of Kv1.3 domains in protein interactions during inflammation.
- To understand Kv1.3's function beyond ion conduction in neuroinflammation.
Main Methods:
- Utilized TurboID proximity labeling fused to Kv1.3 in BV-2 microglia activated by TLR4.
- Employed mass spectrometry to identify interacting proteins.
- Used electrophysiology, Western blotting, and flow cytometry to assess Kv1.3 channel activity and biotinylation.
- Investigated Kv1.3 domain-specific interactions and functional coupling with STAT1.
Main Results:
- Kv1.3 N-terminus mediates trafficking to cell surface and mitochondria (e.g., NUDC, TIMM50).
- Kv1.3 C-terminus interacts with immune signaling proteins (e.g., STAT1, TLR2, C3) during inflammation.
- 70 proteins, including ND3, Snx3, and Sun1, interact with Kv1.3 via its C-terminal PDZ-binding domain.
- Kv1.3 blockade confirmed functional coupling with interferon-mediated STAT1 activation.
Conclusions:
- Kv1.3 channel has roles beyond potassium transport in inflammatory contexts.
- Kv1.3 modulates key immune signaling proteins like STAT1 and C3 in microglia.
- Understanding Kv1.3 interactions provides insights into neuroinflammation and potential therapeutic targets.

